Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation (TAESR)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2011 by Hammersmith Hospitals NHS Trust.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Hammersmith Hospitals NHS Trust
ClinicalTrials.gov Identifier:
NCT00807144
First received: December 10, 2008
Last updated: June 27, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2012
  Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)